Molecular biology of prostate carcinogenesis (Q33816588)

29 July 2017

1 reference

title

Molecular biology of prostate carcinogenesis (English)

1 reference

29 July 2017

0 references

1 reference

Lara PN Jr

1 reference

29 July 2017

Kung HJ

series ordinal

1 reference

29 July 2017

Gumerlock PH

series ordinal

1 reference

29 July 2017

Meyers FJ

series ordinal

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Critical Reviews in Oncology Hematology

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

197-208

1 reference

Allelotype of colorectal carcinomas

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Molecular and cellular biology of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Animal models for the preneoplastic lesions of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Animal models for the study of prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Occupation, cadmium exposure, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Familial patterns of prostate cancer: a case-control analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Family history and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Mendelian inheritance of familial prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Re: Prostate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Allelic loss of chromosomes 16q and 10q in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Cytogenetic analysis of 57 primary prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Trisomy 7: a potential cytogenetic marker of human prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Allelotyping of human prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Infrequent RAS oncogene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

A tyrosine kinase profile of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

p53 gene alterations in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

p53 in prostate cancer: frequent expressed transition mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Alterations of the retinoblastoma gene in human prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

IncreasedRB1 abnormalities in human primary prostate cancer following combined androgen blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Identification of a chromosome 18q gene that is altered in colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Characterization and expression of a cDNA encoding the human androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Triplet repeat mutations in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Androgen receptor gene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Androgen receptor alterations in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Human androgen receptor expression in prostate cancer following androgen ablation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Telomere length predicts replicative capacity of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Peptide growth factors in the prostate as mediators of stromal epithelial interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Molecular advances in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Prostatic epidermal growth factor receptors and their regulation by androgens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Role of transforming growth factor-alpha in human prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Expression of metalloproteinase genes in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Serum metalloproteinases and their inhibitors: markers for malignant potential

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

Chromosomal abnormalities and related events in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900041-4

7 January 2021

10.1016/S1040-8428(99)00041-4

Identifiers

DOI

1 reference

29 July 2017

1 reference